These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1680547

  • 1. Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2.
    Maier LA, Xu FJ, Hester S, Boyer CM, McKenzie S, Bruskin AM, Argon Y, Bast RC.
    Cancer Res; 1991 Oct 01; 51(19):5361-9. PubMed ID: 1680547
    [Abstract] [Full Text] [Related]

  • 2. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
    Xu F, Leadon SA, Yu Y, Boyer CM, O'Briant K, Ward K, McWatters A, Zhao X, Bae DS, DeSombre K, Zalutsky MR, Bast RC.
    Clin Cancer Res; 2000 Aug 01; 6(8):3334-41. PubMed ID: 10955821
    [Abstract] [Full Text] [Related]

  • 3. Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate with and are not required for growth inhibition of human carcinoma cells.
    Shawver LK, Mann E, Elliger SS, Dugger TC, Arteaga CL.
    Cancer Res; 1994 Mar 01; 54(5):1367-73. PubMed ID: 7907001
    [Abstract] [Full Text] [Related]

  • 4. Suppression of diacylglycerol levels by antibodies reactive with the c-erbB-2 (HER-2/neu) gene product p185c-erbB-2 in breast and ovarian cancer cell lines.
    Boente MP, Berchuck A, Whitaker RS, Kalén A, Xu FJ, Clarke-Pearson DL, Bell RM, Bast RC.
    Gynecol Oncol; 1998 Jul 01; 70(1):49-55. PubMed ID: 9698473
    [Abstract] [Full Text] [Related]

  • 5. Radiolabeled antibody targeting of the HER-2/neu oncoprotein.
    De Santes K, Slamon D, Anderson SK, Shepard M, Fendly B, Maneval D, Press O.
    Cancer Res; 1992 Apr 01; 52(7):1916-23. PubMed ID: 1348016
    [Abstract] [Full Text] [Related]

  • 6. Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells.
    Bacus SS, Stancovski I, Huberman E, Chin D, Hurwitz E, Mills GB, Ullrich A, Sela M, Yarden Y.
    Cancer Res; 1992 May 01; 52(9):2580-9. PubMed ID: 1373672
    [Abstract] [Full Text] [Related]

  • 7. Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up.
    Thor AD, Schwartz LH, Koerner FC, Edgerton SM, Skates SJ, Yin S, McKenzie SJ, Panicali DL, Marks PJ, Fingert HJ.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7147-52. PubMed ID: 2573426
    [Abstract] [Full Text] [Related]

  • 8. p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair.
    Arteaga CL, Winnier AR, Poirier MC, Lopez-Larraza DM, Shawver LK, Hurd SD, Stewart SJ.
    Cancer Res; 1994 Jul 15; 54(14):3758-65. PubMed ID: 7913407
    [Abstract] [Full Text] [Related]

  • 9. The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3.
    Alper O, Yamaguchi K, Hitomi J, Honda S, Matsushima T, Abe K.
    Cell Growth Differ; 1990 Dec 15; 1(12):591-9. PubMed ID: 1981143
    [Abstract] [Full Text] [Related]

  • 10. Mutation of the human neu protein facilitates down-modulation by monoclonal antibodies.
    van Leeuwen F, van de Vijver MJ, Lomans J, van Deemter L, Jenster G, Akiyama T, Yamamoto T, Nusse R.
    Oncogene; 1990 Apr 15; 5(4):497-503. PubMed ID: 1970152
    [Abstract] [Full Text] [Related]

  • 11. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
    Weiner LM, Holmes M, Adams GP, LaCreta F, Watts P, Garcia de Palazzo I.
    Cancer Res; 1993 Jan 01; 53(1):94-100. PubMed ID: 8093231
    [Abstract] [Full Text] [Related]

  • 12. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP, Kokeny KE, Ridings JW, Dilts CA.
    Cancer Res; 1996 Feb 15; 56(4):899-907. PubMed ID: 8631031
    [Abstract] [Full Text] [Related]

  • 13. The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired.
    Sorkin A, Di Fiore PP, Carpenter G.
    Oncogene; 1993 Nov 15; 8(11):3021-8. PubMed ID: 8105439
    [Abstract] [Full Text] [Related]

  • 14. The role of erbB-2 and its ligands in growth control of malignant breast epithelium.
    Lupu R, Dickson RB, Lippman ME.
    Princess Takamatsu Symp; 1991 Nov 15; 22():49-60. PubMed ID: 1688228
    [Abstract] [Full Text] [Related]

  • 15. Selection of tumor-specific internalizing human antibodies from phage libraries.
    Poul MA, Becerril B, Nielsen UB, Morisson P, Marks JD.
    J Mol Biol; 2000 Sep 01; 301(5):1149-61. PubMed ID: 10966812
    [Abstract] [Full Text] [Related]

  • 16. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D, Wolf JK, Scanlon M, Price JE, Hung MC.
    Cancer Res; 1993 Feb 15; 53(4):891-8. PubMed ID: 8094034
    [Abstract] [Full Text] [Related]

  • 17. Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes.
    Altenschmidt U, Kahl R, Moritz D, Schnierle BS, Gerstmayer B, Wels W, Groner B.
    Clin Cancer Res; 1996 Jun 15; 2(6):1001-8. PubMed ID: 9816261
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes N, Langton BC, Yokozaki H, Saeki T, Elliott JW, Masui H.
    Cell Growth Differ; 1990 Sep 15; 1(9):407-20. PubMed ID: 1981145
    [Abstract] [Full Text] [Related]

  • 19. Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status.
    Brodowicz T, Kandioler D, Tomek S, Ludwig C, Rudas M, Kunstfeld R, Koestler W, Hejna M, Budinsky A, Wiltschke C, Zielinski CC.
    Br J Cancer; 2001 Nov 30; 85(11):1764-70. PubMed ID: 11742500
    [Abstract] [Full Text] [Related]

  • 20. Generation of monoclonal antibody CIBCgp185 against C-erbB-2 oncoprotein and its clinical evaluation.
    Meenakshi A, Kumar RS, Kumar NS.
    Hum Antibodies; 2001 Nov 30; 10(3-4):101-7. PubMed ID: 11847421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.